middle.news
How Botanix’s Sofdra Sales Soared 171% Despite $33M Loss
3:42pm on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
How Botanix’s Sofdra Sales Soared 171% Despite $33M Loss
3:42pm on Friday 27th of February, 2026 AEDT
Key Points
Revenue jumps from $346K to $16.5M on Sofdra sales ramp-up
Net loss widens slightly to $33.2M due to sales force expansion
Sales team grows from 27 to 50, prescriptions shipped up 171%
Negotiations underway to reduce API costs by 25–40%
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BOTANIX PHARMACEUTICALS (ASX:BOT)
OPEN ARTICLE